These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 29370863)

  • 21. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
    Kim HA; An JM; Nam JY; Jeon JY; Suh CH
    J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
    Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
    J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anakinra in refractory adult onset Still's disease].
    Vercoutere W; Starmans-Kool M; Peeters RM
    Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Still's disease in children and adults].
    Hedrich CM; Günther C; Aringer M
    Z Rheumatol; 2017 Sep; 76(7):595-608. PubMed ID: 28755070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult-onset Still's disease.
    Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
    Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proposal of a new diagnostic algorithm for adult-onset Still's disease.
    Daghor-Abbaci K; Ait Hamadouche N; Makhloufi CD; Mechid F; Otmani F; Makrelouf M; Otmane A; Smail N; Boucelma M; Aissat FZ; Lefkir-Teffiani S; Bengana B; Boukheris N; Tebaibia A; Taharbouchet B; Ayoub S; Benziane B; Oumnia N; Haouichet C; Hanni F; Laraba N; Hakem D; Benfenatki N; Berrah A
    Clin Rheumatol; 2023 Apr; 42(4):1125-1135. PubMed ID: 36694091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still's disease.
    Nigrovic PA; de Benedetti F; Kimura Y; Lovell DJ; Vastert SJ
    Pediatr Rheumatol Online J; 2024 Jan; 21(Suppl 1):114. PubMed ID: 38183114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case Report: A Rare Case of Elderly-Onset Adult-Onset Still's Disease in a Patient With Systemic Lupus Erythematosus.
    Hirooka Y; Okuda S; Sugiyama M; Shiga T; Nozaki Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2022; 13():822169. PubMed ID: 35116046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adult onset Still's disease in northern India: comparison with juvenile onset Still's disease.
    Uppal SS; Pande IR; Kumar A; Kailash S; Sekharan NG; Adya CM; Malaviya AN
    Br J Rheumatol; 1995 May; 34(5):429-34. PubMed ID: 7788171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
    Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
    Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Assessment of MS-Score and HScore in timeliness of diagnosis of macrophage activation syndrome associated with adult-onset Still's disease].
    Peng Z; Gao XM; Zhou S; Wu CY; Zhao JL; Xu D; Li MT; Peng JM; Li J; Wang Q; Tian XF; Zeng X
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2210-2214. PubMed ID: 35872586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
    Lenert A; Yao Q
    Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adult-onset Still's disease].
    Fliciński J; Milchert M; Ostanek L; Brzosko I; Przepiera-Bedzak H; Prajs K; Brzosko M
    Ann Acad Med Stetin; 2006; 52 Suppl 2():111-4. PubMed ID: 17471846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort.
    Kalyoncu U; Solmaz D; Emmungil H; Yazici A; Kasifoglu T; Kimyon G; Balkarli A; Bes C; Ozmen M; Alibaz-Oner F; Erten S; Cagatay Y; Cetin GY; Yilmaz S; Yildiz F; Pamuk ON; Kucuksahin O; Kilic L; Yazisiz V; Karadag O; Koca SS; Hayran M; Akar S; Aksu K; Akkoc N; Keser G; Gonullu E; Kisacik B; Onat AM; Soy M; Inanc N; Direskeneli H; Sayarlioglu M; Erken E; Turgay M; Cefle A; Ertenli I; Pay S
    J Autoimmun; 2016 May; 69():59-63. PubMed ID: 26970681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis.
    Seo JY; Suh CH; Jung JY; Kim AR; Yang JW; Kim HA
    Medicine (Baltimore); 2017 Jul; 96(29):e7546. PubMed ID: 28723775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis.
    Pay S; Türkçapar N; Kalyoncu M; Simşek I; Beyan E; Ertenli I; Oztürk MA; Düzgün N; Erdem H; Ozbalkan Z; Kiraz S; Kinikli G; Besbas N; Dinç A; Ateş A; Olmez U; Calgüneri M; Aydintuğ OT; Bakkaloğlu A; Turan M; Turgay M; Karaaslan Y; Topaloğlu R; Duman M; Ozen S;
    Clin Rheumatol; 2006 Sep; 25(5):639-44. PubMed ID: 16365690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still's Disease.
    Sun Z; Li R; Wang Y; Han F; Wei W; Li X
    Drugs R D; 2023 Jun; 23(2):109-120. PubMed ID: 37010773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review.
    Cota-Arce JM; Cota J; De León-Nava MA; Hernández-Cáceres A; Moncayo-Salazar LI; Valle-Alvarado F; Cordero-Moreno VL; Bonfil-Solis KL; Bichara-Figueroa JE; Hernández-Hernández J; Villela L
    Semin Arthritis Rheum; 2021 Dec; 51(6):1282-1290. PubMed ID: 34493394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of HLA-DRB1 alleles on susceptibility and clinical manifestations in Japanese patients with adult onset Still's disease.
    Asano T; Furukawa H; Sato S; Yashiro M; Kobayashi H; Watanabe H; Suzuki E; Ito T; Ubara Y; Kobayashi D; Iwanaga N; Izumi Y; Fujikawa K; Yamasaki S; Nakamura T; Koga T; Shimizu T; Umeda M; Nonaka F; Yasunami M; Ueki Y; Eguchi K; Tsuchiya N; Tohma S; Yoshiura KI; Ohira H; Kawakami A; Migita K
    Arthritis Res Ther; 2017 Sep; 19(1):199. PubMed ID: 28899403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.